Amylyx Pharmaceuticals Investor Lawsuit: Overstated Drug Potential?by Mark Eisenberg 13.02.2024Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...